Epstein-barr virus serology in the management of recurrent nasopharyngeal carcinoma

Prediction of surgical outcome using plasma epstein-barr virus dna and 18F-FDG PET-CT scan in recurrent nasopharyngeal carcinoma

Head & Neck ◽

10.1002/hed.21768 ◽

2011 ◽

Vol 34 (4) ◽

pp. 541-545 ◽

Cited By ~ 13

Author(s):

Jimmy Yu Wai Chan ◽

Velda Ling Yu Chow ◽

Vivian Way Kay Mok ◽

Ambrose Chung Wai Ho ◽

William Ignace Wei

Keyword(s):

Nasopharyngeal Carcinoma ◽

Surgical Outcome ◽

Epstein Barr Virus ◽

Barr Virus ◽

Pet Ct ◽

Recurrent Nasopharyngeal Carcinoma ◽

18F Fdg ◽

Epstein Barr ◽

Fdg Pet Ct ◽

Pet Ct Scan

Download Full-text

P52. Prediction of surgical outcome using plasma Epstein–Barr virus DNA and 18F-FDG PET-CT scan in recurrent nasopharyngeal carcinoma

Oral Oncology ◽

10.1016/j.oraloncology.2011.06.295 ◽

2011 ◽

Vol 47 ◽

pp. S91

Author(s):

J.Y.W. Chan ◽

W.I. Wei

Keyword(s):

Nasopharyngeal Carcinoma ◽

Surgical Outcome ◽

Epstein Barr Virus ◽

Barr Virus ◽

Pet Ct ◽

Recurrent Nasopharyngeal Carcinoma ◽

18F Fdg ◽

Epstein Barr ◽

Fdg Pet Ct ◽

Pet Ct Scan

Download Full-text

The role of Epstein-Barr virus-encoded microRNA BART7 status of resection margins in the prediction of local recurrence after salvage nasopharyngectomy for recurrent nasopharyngeal carcinoma

Cancer ◽

10.1002/cncr.29380 ◽

2015 ◽

Vol 121 (14) ◽

pp. 2358-2366 ◽

Cited By ~ 9

Author(s):

Jimmy Yu Wai Chan ◽

Stanley Thian Sze Wong ◽

William Ignace Wei

Keyword(s):

Nasopharyngeal Carcinoma ◽

Local Recurrence ◽

Epstein Barr Virus ◽

Resection Margins ◽

Barr Virus ◽

Recurrent Nasopharyngeal Carcinoma ◽

Epstein Barr

Download Full-text

Plasma Epstein-Barr virus DNA level strongly predicts survival in metastatic/recurrent nasopharyngeal carcinoma treated with palliative chemotherapy

Cancer ◽

10.1002/cncr.25932 ◽

2011 ◽

Vol 117 (16) ◽

pp. 3750-3757 ◽

Cited By ~ 87

Author(s):

Xin An ◽

Feng-Hua Wang ◽

Pei-Rong Ding ◽

Ling Deng ◽

Wen-Qi Jiang ◽

...

Keyword(s):

Nasopharyngeal Carcinoma ◽

Epstein Barr Virus ◽

Palliative Chemotherapy ◽

Barr Virus ◽

Recurrent Nasopharyngeal Carcinoma ◽

Epstein Barr

Download Full-text

Prospective evaluation of plasma Epstein–Barr virus DNA clearance and fluorodeoxyglucose positron emission scan in assessing early response to chemotherapy in patients with advanced or recurrent nasopharyngeal carcinoma

British Journal of Cancer ◽

10.1038/s41416-018-0026-9 ◽

2018 ◽

Vol 118 (8) ◽

pp. 1051-1055 ◽

Cited By ~ 5

Author(s):

Brigette Ma ◽

Edwin P Hui ◽

Ann King ◽

Sing F Leung ◽

Michael KM Kam ◽

...

Keyword(s):

Nasopharyngeal Carcinoma ◽

Epstein Barr Virus ◽

Early Response ◽

Prospective Evaluation ◽

Barr Virus ◽

Positron Emission ◽

Response To Chemotherapy ◽

Recurrent Nasopharyngeal Carcinoma ◽

Epstein Barr ◽

Fluorodeoxyglucose Positron Emission

Download Full-text

Differentiation of Recurrent Nasopharyngeal Carcinoma and Skull Base Osteoradionecrosis by Epstein-Barr Virus-Derived Latent Membrane Protein-1 Gene

The Laryngoscope ◽

10.1097/00005537-200104000-00017 ◽

2001 ◽

Vol 111 (4) ◽

pp. 650-652 ◽

Cited By ~ 11

Author(s):

Sheng-Po Hao ◽

Ngan-Ming Tsang ◽

Kai-Ping Chang

Keyword(s):

Nasopharyngeal Carcinoma ◽

Membrane Protein ◽

Skull Base ◽

Epstein Barr Virus ◽

Latent Membrane Protein ◽

Latent Membrane Protein 1 ◽

Barr Virus ◽

Recurrent Nasopharyngeal Carcinoma ◽

Epstein Barr

Download Full-text

The role of plasma Epstein‐Barr virus DNA in the management of recurrent nasopharyngeal carcinoma

The Laryngoscope ◽

10.1002/lary.24193 ◽

2013 ◽

Vol 124 (1) ◽

pp. 126-130 ◽

Cited By ~ 24

Author(s):

Jimmy Yu Wai Chan ◽

Stanley Thian‐Sze Wong

Keyword(s):

Nasopharyngeal Carcinoma ◽

Epstein Barr Virus ◽

Barr Virus ◽

Recurrent Nasopharyngeal Carcinoma ◽

Epstein Barr

Download Full-text

Can Epstein-Barr virus DNA load in nasopharyngeal brushings or whole blood predict recurrent nasopharyngeal carcinoma in a non-endemic region? A prospective nationwide study of the Dutch Head and Neck Oncology Cooperative Group

European Archives of Oto-Rhino-Laryngology ◽

10.1007/s00405-015-3620-y ◽

2015 ◽

Vol 273 (6) ◽

pp. 1557-1567 ◽

Cited By ~ 11

Author(s):

Sharon D. Stoker ◽

Maarten A. Wildeman ◽

Zlata Novalic ◽

Renske Fles ◽

Vincent van der Noort ◽

...

Keyword(s):

Nasopharyngeal Carcinoma ◽

Whole Blood ◽

Epstein Barr Virus ◽

Cooperative Group ◽

Head And Neck Oncology ◽

Endemic Region ◽

Nationwide Study ◽

Barr Virus ◽

Recurrent Nasopharyngeal Carcinoma ◽

Epstein Barr

Download Full-text

Clinical characteristics and prognostic value of pre‐retreatment plasma epstein‐barr virus DNA in locoregional recurrent nasopharyngeal carcinoma

Cancer Medicine ◽

10.1002/cam4.2339 ◽

2019 ◽

Vol 8 (10) ◽

pp. 4633-4643 ◽

Cited By ~ 4

Author(s):

Ming‐Zhu Liu ◽

Shuo‐Gui Fang ◽

Wei Huang ◽

Han‐Yu Wang ◽

Yun‐Ming Tian ◽

...

Keyword(s):

Nasopharyngeal Carcinoma ◽

Prognostic Value ◽

Clinical Characteristics ◽

Epstein Barr Virus ◽

Barr Virus ◽

Recurrent Nasopharyngeal Carcinoma ◽

Epstein Barr

Download Full-text

A phase II study of patients with metastatic or locoregionally recurrent nasopharyngeal carcinoma and evaluation of plasma Epstein–Barr virus DNA as a biomarker of efficacy

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-007-0575-8 ◽

2007 ◽

Vol 62 (1) ◽

pp. 59-64 ◽

Cited By ~ 47

Author(s):

Brigette Ma ◽

Edwin P. Hui ◽

Ann King ◽

K. F. To ◽

Frankie Mo ◽

...

Keyword(s):

Nasopharyngeal Carcinoma ◽

Phase Ii ◽

Epstein Barr Virus ◽

Phase Ii Study ◽

Barr Virus ◽

Recurrent Nasopharyngeal Carcinoma ◽

Epstein Barr

Download Full-text